PDT Partners’s Vera Therapeutics VERA Stock Holding History

PDT Partners’s Portfolio VERA Stock Details VERA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-18,714	Closed	-$300K	–	686
2023 Q2	$300K	Buy	+18,714	New	+$169K	0.04%	452

Other funds holding VERA

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

PDT Partners's VERA Position: Q3 2023 in Review

PDT Partners sold out of Vera Therapeutics (VERA) in Q3 2023, closing a stake of 18,714 shares — an estimated $300K sold.

PDT Partners first reported a position in VERA in Q2 2023 and held it in 1 quarter. The position peaked at $300K in Q2 2023. 84 funds tracked by Wall St. Rank hold VERA as of Q3 2023.

PDT Partners reported no remaining Vera Therapeutics position as of Q3 2023 after selling out during the quarter.
PDT Partners sold 18,714 Vera Therapeutics shares in Q3 2023, an estimated $300K.
PDT Partners first reported a position in Vera Therapeutics in Q2 2023 and held it in 1 quarter.
PDT Partners's Vera Therapeutics position peaked at $300K in Q2 2023.
84 funds tracked by Wall St. Rank held Vera Therapeutics as of Q3 2023.

Based on PDT Partners's 13F filing for Q3 2023, filed 14 Nov 2023.